Duplex RTqPCRs for detection and relative quantification of SARS-CoV-2 variants of concern (VOC)

doi:10.21203/rs.3.pex-1688/v4

Method Article

Duplex RTqPCRs for detection and relative quantification of SARS-CoV-2 variants of concern (VOC)

https://doi.org/10.21203/rs.3.pex-1688/v4

This work is licensed under a CC BY 4.0 License

This protocol has been posted on Protocol Exchange, an open repository of community-contributed protocols sponsored by Nature Portfolio. These protocols are posted directly on the Protocol Exchange by authors and are made freely available to the scientific community for use and comment.

Version 4

posted

You are reading this latest protocol version

During the evolution of the SARS-CoV-2 pandemic, new variants of the virus have emerged and spread worldwide. The increased transmissibility and proclivity of some of these variants to cause more serious disease threatens public health responses against the virus, thus being its monitoring relevant. While Next-Generation-Sequencing (NGS) is the gold standard to identify variants, it cannot always be rapidly implemented in some settings to provide information as an early warning tool. Duplex quantitative real time RTqPCR assays offer a sensitive and easy-to-use tool to detect, discriminate, and estimate relative proportions of SARS-CoV-2 variants containing signature mutations from variants lacking it, using allelic discrimination probes. We developed ten multiplexed RTqPCR assays that can detect Alpha (B.1.1.7), Beta (B.1.351), Gamma (P.1), Delta (B.1.617.2), Omicron (B.1.1.529), Omicron BA.1 (B.1.1.529.1), Omicron BA.2 (B.1.1.529.2), Omicron FLip (XBB.1.5-like + L455F + F456L), Omicron BA.2.86 (B.1.1.529.2.86) and Omicron DeFLiRT (JN.1 + delS31) variants by targeting 21765_21770DelTACATG, 22281_22289DelCTTTACTTG, 28262_28263InsAACA, 22029_22034DelAGTTCA, 28362_28370DelGAGAACGCA, 22121InsGAGCCAGAA, 21633_21641DelTACCCCCTG, G22927T, T22928C and T22930A (L455F and F456L SNVs), ins21610ATGCCGCTGTTT and 21654_21656DelCTT deletions, insertions and SNVs in their genomes. Alpha, Beta, Delta, Omicron BA.1, Omicron BA.2, Omicron Flip, Omicron BA.2.86 and Omicron DeFLiRT markers are mapped to the S gene (residues 69/70, 241/243, 157/158, 214, 25/27, 455/456, 16 and 31 respectively), Gamma insertion is located between the end of ORF8 and the beginning of N gene, and Omicron (B.1.1.529) deletion is mapped to the N gene (residues 31/33). The duplex RTqPCR assay targeting 21765-21770DelTACATG mutation affecting residues HV69/70 has been previously used to estimate the relative proportion of Alpha VOC (Carcereny et al., 2021), and is also suitable to estimate the proportions of Omicron BA.4 and BA.5. All duplex RTqPCR assays targeting signature mutations may be used as a complementary tool to NGS for rapid variant tracking and surveillance in wastewater-based epidemiology.

Molecular biology

Microbiology

SARS-CoV-2

Variants of Concern (VOC)

duplex RTqPCR

allelic discrimination probes

· One Step PrimeScript™ RT-PCR Kit (Perfect Real Time) (RR064A, Takara)

· Twist Synthetic SARS-CoV-2 RNA Control 2 (MN908947.3) (102024, Twist Bioscience)

· Twist Synthetic SARS-CoV-2 RNA Control 16 (EPI_ISL_678597) (104043, Twist Bioscience)

· Twist Synthetic SARS-CoV-2 RNA Control 17 (EPI_ISL_792683) (104044, Twist Bioscience)

· Twist Synthetic SARS-CoV-2 RNA Control 23 (EPI_ISL_1544014) (104533, Twist Bioscience)

· Twist Synthetic SARS-CoV-2 RNA Control 48 (EPI_ISL_6841980) (105204, Twist Bioscience)

· Twist Synthetic SARS-CoV-2 RNA Control 50 (EPI_ISL_7190366) (105345, Twist Bioscience)

· FLip (L455F + F456L) custom synthetic DNA (EPI_ISL_17762415) (Table 1)

· FLip-T22930A (L455F + F456L) custom synthetic DNA (EPI_ISL_18210482) (Table 1)

· Non-FLip custom synthetic DNA (EPI_ISL_18094559) (Table 1)

· Non-BA.2.86 custom synthetic DNA (EPI_ISL_18118690) (Table 1)

· BA.2.86 custom synthetic DNA (EPI_ISL_18096761) (Table 1)

· Del_S31 custom synthetic DNA (EPI_ISL_19071317) (Table 1)

· Non-Del_S31 custom synthetic DNA (EPI_ISL_18096761) (Table 1)

· Nuclease-free water

· Primers/Probes (Table 2)

· Bio-Rad CFX96 touch real-time PCR detection system

· Composition of duplex RTqPCR mastermixes (final volume of RTqPCR reaction of 20 µl)

Alpha^a, Beta, Delta, Omicron (B.1.1.529), Omicron BA.1, Omicron BA.2, Omicron BA.2.86 and Omicron DeFLiRT RTqPCR

2x One Step: 10 µl

Forward primer 10µM: 0.8 µl (400 nm)

Reverse primer 10µM: 0.8 µl (400 nm)

Probe_Variant 10µM: 0.4 µl (200 nm)

Probe_NoVariant 10µM: 0.4 µl (200 nm)

Takara Ex Taq: 0.4 µl

Prime Script Enzyme: 0.4 µl

H₂O PCR: 1.8 µl

Extracted RNA: 5 µl

^a21765_21770DelTACATG (deletion 69/70) is also a marker for Omicron BA.4 and BA.5

Gamma RTqPCR

2x One Step: 10 µl

Forward primer 10µM: 0.8 µl (400 nm)

Reverse primer 10µM: 0.8 µl (400 nm)

Probe_Gamma 10µM: 0.4 µl (200 nm)

Probe_NoGamma1 10µM: 0.2 µl (100 nm)

Probe_NoGamma2 10µM: 0.2 µl (100 nm)

Takara Ex Taq: 0.4 µl

Prime Script Enzyme: 0.4 µl

H₂O PCR: 1.8 µl

Extracted RNA: 5 µl

Omicron FLip RTqPCR

2x One Step 10 (µl)

Forward primer 10uM: 0.8 µl (400nm)

Reverse primer 10uM: 0.8 µl (400nm)

Probe_FLip_T22928C 10uM: 0.2 µl (100nm)

Probe_Flip_T22930A 10uM: 0.2 µl (100nm)

Probe_No_FLip_G22927G 10uM: 0.2 µl (100nm)

Probe_No_FLip_T22927T 10uM: 0.2 µl (100nm)

Takara Ex Taq: 0.4 µl

Prime Script Enzyme: 0.4 µl

H₂O PCR: 1.8 µl

Extracted RNA: 5 µl

· Controls to be included in each RTqPCR assay:

o 2 wells with 5 µl of nuclease-free water (RTqPCR negative controls)

o 2 wells with 5 µl of RNA extraction negative control (RNA extraction negative controls)

o 1 well with 5 µl of each corresponding synthetic SARS-CoV-2 RNA controls (or synthetic DNA for Omicron FLip, BA.2.86 and DeFLiRT assays) at 1000 copies/µL (RTqPCR positive controls).

· For each sample, 2 wells of undiluted RNA and 2 wells of 1/10 dilution are analyzed.

· For quantification of each target, standard curves are constructed, using a minimum of 5 10-fold dilutions and 3 wells for each dilution, using 2 synthetic SARS-CoV-2 RNA controls or 2 synthetic DNA for Omicron FLip, Omicron BA.2.86 and Omicron DeFLiRT assay as reference materials (one corresponding to the variant containing the specific mutation and another corresponding to a variant without the specific mutation).

· Thermocycler conditions (common for all duplex RTqPCR assays except for Omicron BA.2, FLip, BA.2.86 and DeFLiRT)

- 10 min at 50ºC (x1)

- 3 min at 95ºC (x1)

- 3 sec at 95ºC and 30 sec at 60ºC (x45)

· Thermocycler conditions for Omicron BA.2

- 10 min at 50ºC (x1)

- 3 min at 95ºC (x1)

- 3 sec at 95ºC and 45 sec at 58ºC (x45)

· Thermocycler conditions for Omicron FLip

- 10 min at 50ºC (x1)

- 3 min at 95ºC (x1)

- 3 sec at 95ºC and 30 sec at 54ºC (x45)

· Thermocycler conditions for BA.2.86 and DeFLiRT

- 10 min at 50ºC (x1)

- 3 min at 95ºC (x1)

- 3 sec at 95ºC and 30 sec at 58ºC (x45)

INTERPRETATION OF RESULTS

a) RTqPCR controls (see Tables 3 to 12)

b) Samples

· The calculation of each specific SARS-CoV-2 target concentration in genome copies per reaction (gc/rxn) in each well is performed using the standard curve.

· Occurrence of inhibition and calculation of mean viral titers are estimated by comparing concentrations obtained from duplicate wells tested for the two RNA dilutions (undiluted RNA and 1/10 dilution), as described in Carcereny et al., 2021 (1). Mean concentration of samples and standard error are calculated using as many data as possible, taking into consideration the following steps:

a. Calculate mean concentration as gc/rxn for each RNA dilution:

ai. Data from RNA dilutions containing “No Cq” or Cq≥40 in both wells are not be used for calculation.

aii. When in the analysis of the 2 wells of any RNA dilution, one of the wells has a Cq value <40 and the other has "No Cq" or Cq≥40, this last well is assigned a concentration equal to the theoretical limit of detection (LoD) of 1 gc/rxn.

b. Calculate mean concentration as gc/rxn for each sample:

bi. When the difference between the concentration estimated from undiluted RNA and 1/10 dilution is < 0.5 log₁₀, mean concentration of sample is calculated using data from the 4 wells.

bii. When the difference between the concentration estimated from undiluted RNA and 1/10 dilution is ≥ 0.5 log₁₀, inhibition is considered and mean concentration of sample is calculated using data from the 1/10 dilution.

· The proportion of SARS-CoV-2 genomes corresponding to variants containing the specific signature mutation is calculated using the formula (example):

Delta Duplex RTqPCR:

% = gc/rxn (Probe_Delta) / [gc/rxn (Probe_Delta) + cg/rxn (Probe_NoDelta)] x 100

· Cases in which any of the concentrations fall below the limit of quantification (LoQ), the percentage is calculated using the corresponding LoQ. When both concentrations are <LoQ, percentage cannot be estimated.

1. Carcereny A. et al. Monitoring Emergence of the SARS-CoV-2 B.1.1.7 Variant through the Spanish National SARS-CoV-2 Wastewater Surveillance System (VATar COVID-19). Environ. Sci. & Technol. 55(17):11756–11766 (2021). Available from: https://doi.org/10.1021/acs.est.1c03589

Tables.pdf

Download PDF

Version 4

posted

You are reading this latest protocol version

Duplex RTqPCRs for detection and relative quantification of SARS-CoV-2 variants of concern (VOC)

Status:

Version 4

Abstract

Reagents

Equipment

Procedure

References

Supplementary Files

Status:

Version 4

Privacy Policy

Terms of Service

Duplex RTqPCRs for detection and relative quantification of SARS-CoV-2 variants of concern (VOC)

Status:

Version 4

Abstract

Reagents

Equipment

Procedure

References

Supplementary Files

Status:

Version 4

Privacy Policy

Terms of Service

Manage Cookie Preferences